Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Opinion Volume 4 Issue 9

Cancer Energy Metabolism

Daniel Gandia*

IQVIA and Department of Cancer Medicine, Buenos Aires, Argentina

*Corresponding Author: Daniel Gandia, IQVIA and Department of Cancer Medicine, Buenos Aires, Argentina.

Received: July 27, 2020; Published: August 19, 2020


Cancer is a disease with dominant genetic traits that continuously evolves during the whole tumor lifecycle. This evolution is present at the different biological organization levels meaning molecular-cell and tissue-related ones.

The process comports one of the highest medical challenges and disease complexities, metastases, that if not correctly treated, the patient presents a clinical deterioration that can lead to a clinical starvation condition.





Citation: Daniel Gandia. “Cancer Energy Metabolism". Acta Scientific Pharmaceutical Sciences 4.9 (2020): 131-132.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US